trans-1-(tert-Butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylicacid CAS:169248-97-9

Trans-1-(tert-Butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid is commonly utilized as an intermediate in pharmaceutical synthesis. It serves as a crucial building block for the development of drug candidates targeting diverse therapeutic areas such as inflammation, oncology, and infectious diseases. The compound's unique structure allows for the modulation of pharmacological properties and enhancement of biological activity, making it valuable in drug discovery. Moreover, this compound finds application in academic research for investigating new synthetic routes and exploring structure-activity relationships. Researchers leverage its reactivity to design and synthesize novel molecules with potential pharmacological activities, contributing to advancements in drug development and scientific knowledge. Additionally, trans-1-(tert-Butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid is employed in the development of peptide-based therapeutics and prodrugs. Its versatile nature and functional groups offer opportunities for designing compounds with controlled release and improved bioavailability, facilitating drug delivery strategies and enhancing therapeutic outcomes. In summary, trans-1-(tert-Butoxycarbonyl)-4-(3-(trifluoromethyl)phenyl)pyrrolidine-3-carboxylic acid plays a crucial role as an intermediate in pharmaceutical research, drug discovery, and academic investigations. Its diverse applications underscore its significance in advancing scientific knowledge and developing innovative solutions in organic chemistry and medicinal science.